Sort
82,697 grants matching “vaccine development”
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody
$750,000Ram Sasisekharan · Massachusetts Institute Of Technology · R01 · FY2015 · AI
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody
$750,000Ram Sasisekharan · Massachusetts Institute Of Technology · R01 · FY2014 · AI
NSF Convergence Accelerator Track F: How Large-Scale Identification and Intervention Can Empower Professional Fact-Checkers to Improve Democracy and Public Health
$750,000Michael W Wagner · University Of Wisconsin-Madison · · FY2021 · TIP
Individual-based Simulation of Seasonal and Pandemic Influenza Epidemics - supplement Emergency Response to the COVID-19 Pandemic
$750,000Mark Stenius Roberts · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · IP
Nanoliter Lab-on-a-Chip for Rapid Parallel Immunoassays
$750,000Vamsee K Pamula · Advanced Liquid Logic · R44 · FY2008 · CA
RFA-IP-20-003, FluMod - Center for the Multiscale Modeling of Pandemic and seasonal Flu Prevention and Control
$750,000Alessandro Vespignani · Northeastern University · U01 · FY2023 · IP
11th IAS Conference on HIV Science (IAS 2021), Berlin, Germany, 18-21 July 2021
$750,000Chris Beyrer · Ias · R13 · FY2021 · AI
Individual-based Simulation of Seasonal and Pandemic Influenza Epidemics - supplement Emergency Response to the COVID-19 Pandemic
$750,000Mark Stenius Roberts · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · IP
LAB SUP. FOR AIDS VACCINE &OTHER PREVENT. CLINICAL TRIA
$750,000Seracare Bioservices · N01 · FY2000 · AI
Vanderbilt Meharry Developmental CFAR
$750,000Vanderbilt University · P30 · FY2003 · AI
Individual-based Simulation of Seasonal and Pandemic Influenza Epidemics - supplement Emergency Response to the COVID-19 Pandemic
$750,000Mark Stenius Roberts · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · IP
FluMod - Center for the Multiscale Modeling of Pandemic and seasonal Flu Prevention and Control
$750,000Alessandro Vespignani · Northeastern University · U01 · FY2022 · IP
Sickle Cell post Transplantation Long Term and Late Effects Registry ( STELLAR)
$750,000Lakshmanan Krishnamurti · Emory University · OT2 · FY2019 · HL
20th International AIDS Conference (AIDS 2014), Melbourne, Australia, 20-25 July
$750,000Chris Beyrer · Ias · R13 · FY2014 · AI
FluMod - Center for the Multiscale Modeling of Pandemic and seasonal Flu Prevention and Control
$750,000Alessandro Vespignani · Northeastern University · U01 · FY2021 · IP
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody
$750,000Ram Sasisekharan · Massachusetts Institute Of Technology · R01 · FY2016 · AI
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody
$750,000Ram Sasisekharan · Massachusetts Institute Of Technology · R01 · FY2017 · AI
University of Pittsburgh Clinical and Translational Science Institute
$750,000Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2020 · TR
Columbia University-Southern African AIDS International Training/Research Program
$750,000Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2013 · TW
Development and cGMP Manufacture of a Vitrified Typhoid Vaccine
$750,000Sims K Kochi · Celldex Therapeutics, Inc. · R44 · FY2006 · AI
RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
$749,999Emmanuel B Walter · Duke University · U01 · FY2025 · IP
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
$749,998Mark E. Peeples · Research Inst Nationwide Children'S Hosp · P01 · FY2015 · AI
Structural Vaccinology and Design of Novel Imunogens for Malaria Vaccine Development
$749,945Daniel E Goldberg · Washington University · R01 · FY2018 · AI
Rapid Point-of-Care Assay for detecting High Risk Human Papillomavirus
$749,896David Lee Dolinger · Iquum, Inc. · R44 · FY2008 · CA
Disease Determinants of Urban Leptospirosis
$749,874Albert Icksang Ko · Yale University · U01 · FY2010 · AI